Skip to main content
Caplight Logo









Gel Coat Biomaterials, Inc.

Gel Coat Biomaterials, Inc.

Private
TokyoHealthcare & Life Scienceshttps://www.gelcoatbio.com/

Last Round

Series A

Apr 27, 2026

Total Funding Raised

$2.62M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Gel Coat Biomaterials, Inc. is a biotechnology company that develops novel hydrogel technology for the stabilization of enzymes and other biomolecules.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biomaterial coatingsmedical device coatingshydrogel coatingsmedtech coatingsbiocompatibilitybio-coatingsurface modificationimplant coatingimplantable devicesmedical device surfacebiotech licensingzwitterionic polymersmedical device R&Dbio-interfacebiotech IP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gel Coat Biomaterials, Inc. Comparables

Compare Gel Coat Biomaterials, Inc. with similar companies based on industry and business-model similarity.

Gel Coat Biomaterials, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biocoat Incorporated
74%
Hydromer Inc.
73%
SurModics Inc
73%

Gel Coat Biomaterials, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 27, 2026
SeedFeb 22, 2024

Gel Coat Biomaterials, Inc. Investors

Notable investors and investment history

Gel Coat Biomaterials, Inc. investors
InvestorRounds
WASEDA University VenturesSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 27, 2026

    $1.26M round led by WASEDA University Ventures

  • Apr 20, 2026

    Monthly visitors increased 31% MoM.

Gel Coat Biomaterials, Inc. Filings

Explore SEC and related filing metadata, where available.

Gel Coat Biomaterials, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Gel Coat Biomaterials, Inc.'s valuation, stock price, and market status.

Is Gel Coat Biomaterials, Inc. a public or private company?

Gel Coat Biomaterials, Inc. is a private company.

What is the current stock price of Gel Coat Biomaterials, Inc.?

Gel Coat Biomaterials, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Gel Coat Biomaterials, Inc. worth (valuation)?

Valuation information for Gel Coat Biomaterials, Inc. is not publicly available.

Can I buy Gel Coat Biomaterials, Inc. stock?

Gel Coat Biomaterials, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Gel Coat Biomaterials, Inc.'s last funding round?

Gel Coat Biomaterials, Inc.'s most recent funding round was Series A on April 27, 2026.

Who are the main investors in Gel Coat Biomaterials, Inc.?

Key investors in Gel Coat Biomaterials, Inc. include WASEDA University Ventures.

Will Gel Coat Biomaterials, Inc. IPO soon?

No public IPO plans have been announced for Gel Coat Biomaterials, Inc..

How can I track Gel Coat Biomaterials, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gel Coat Biomaterials, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTokyo
Employee Range2
Year Founded2024
Last FundingApr 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?